Cited by 1,411Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Open access

Austin, M A, King, M C, Vranizan, K M, Krauss, R M·1990·Circulation

DOI 10.1161/01.cir.82.2.495

Open this paper in CoChat — free account Open PDF

Abstract

In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.82.2.495

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885
Applied linear statistical models : regression, analysis of variance, and experimental designs
Neter, J., Wasserman, W., & Kutner, M. (1974) · Andalas University Repository (Andalas University) · Cited by 2,818
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 13

Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364
Heiss G, Tyroler HA: Are apolipoproteins useful for evaluat- ing ischemic heart disease? A brief overview of the literature, in Lippel K (ed): Proceeding ofthe Workshop on Apolipoprotein Quantification. National Institutes of Health publication No. (NIH) 83-1266, 1983, pp 7-19
Krauss RM, Lindgren FT, Williams PT, Kelsy SF, Brensike J, Vranizan K, Detre KM, Levy RI: Intermediate density lipo- proteins and coronary artery disease progression in hypercho- lesterolemic men. Lancet 1987;2:62-66
Ernst N, Fisher M, Smith W, Gordon W, Rifkind BM, Little JA, Mishkel MA, Williams DO: The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: The Lipid Research Clinics Program Prevalence Study. Circulation: 1980;62:41-52
Lindgren FT, Jensen LC, Hatch FT: The isolation and quan- titative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181-274
Morton NE, Rao DC, Lalouel JM: Methods in genetic epi- demiology, in Klingberg MA (ed): Contributions to Epidemiol- ogy and Biostatistics. Basel, Karger, vol 4, 1983, pp 62-102
Snedecor GW, Cochran WG: Statistical Methods, ed 6. Ames, Iowa, Iowa State University Press, 1967
SAS Users Guide: Basics, Version 5 Edition.
SAS User Guide: Statistics, Version 5 Edition.
Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangeiwaia S: Triglyceride and Coronary Heart Disease Mortal- ity. The Lipid Research Clinics Follow-up Study presented at the American Heart Association 27th Conference on Cardio- vascular Disease Epidemiology, Chapel Hill, NC, 1987
Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate density lipoproteins with smoking and coronary heart disease. Circulation 1987; 75:124-130
Swinkels DW, Demacker PNM, Hendricks JCM, van t'Laar A: Low density lipoprotein subfractions and relationship to other risk factors in healthy individuals. Arteriosclerosis 1989; 9:604-613
Krauss RM, Albers JJ, Brunzell JD: An apolipoprotein B- enriched low density lipoprotein subspecies in familial com- bined hyperlipidemia. Clin Res 1983;31:503a

Sorted by citations

Items 701–800 of 1,000

On-Chip Lipid Extraction Using Superabsorbent Polymers for Mass Spectrometry
Bang, G., Kim, Y. H., Yoon, J., Yu, Y. J., Chung, S. H., & Kim, J. A. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03547 · Cited by 21
Comparison of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol for Identifying Coronary Artery Disease Risk Based on Receiver Operating Curve Analysis
Levinson, S. S. (2007) · American Journal of Clinical Pathology · doi:10.1309/22m22rf48px9ut9t · Cited by 21
Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study
Choquette, A., Bouchard, L., Houde, A., Bouchard, C., Përusse, L., & Vohl, M. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00755.x · Cited by 21
Dietary, Physiological, and Genetic Impacts on Postprandial Lipid Metabolism
López‐Miranda, J., & Marı́n, C. (2009) · Frontiers in neuroscience · doi:10.1201/9781420067767-c17 · Cited by 21
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL‐profiles
Winkler, K. E., Schewe, T., Pütz, G., Ödünc, N., Schäfer, G., Siegel, E. G., Geisen, U., Abletshauser, C., & Hoffmann, M. M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02126.x · Cited by 21
CETP gene mutation (D442G) increases low-density lipoprotein particle size in patients with coronary heart disease
Wang, J., Qiang, H., Chen, D., Zhang, C., & Zhuang, Y. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00128-6 · Cited by 21
Familial lipoprotein disorders and premature coronary artery disease
Schaefer, E. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30175-4 · Cited by 21
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213617 · Cited by 21
Metabolism of Triglyceride-Rich Lipoproteins
Borén, J., & Taskinen, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_520 · Cited by 22
“Several studies indicate that increased sdLDL is associated with increased CVD risk (Austin et al. 1990; Lamarche et al. 1997; Gardner et al. 1996; Vakkilainen et al. 2003).”
Background
Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease
Inyaku, M., Tanaka, M., Sato, T., Endo, K., Mori, K., Hosaka, I., Mikami, T., Umetsu, A., Ohnishi, H., Akiyama, Y., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64369 · Cited by 20
“Electrophoresis is the gold standard method for measurement of LDL particle size to evaluate sdLDL 9, 10) , but it is time-consuming and labor-intensive.”
Method
The effect of nandrolone treatment with and without enforced swimming on histological and biochemical changes in the heart and coronary artery of male rats
Tofighi, A. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.7333 · Cited by 20
“Reduced plasma HDL level has been established as major risk factor of heart disease (26, 27).”
BackgroundInfluential
Low-Density Lipoprotein Triglycerides
Miller, M. J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.541 · Cited by 20
“, fasting TG levels <100 mg/dl), very low-density lipoprotein is efficiently converted to LDL via hydrolysis of TGs by lipoprotein lipase (LPL) and hepatic lipase (HL); LDL particles are predominantly large, buoyant, and TG depleted (16).”
Background
Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes
Žitňanová, I., Oravec, S., Janubova, M., Koňariková, K., Dvořáková, M., Laubertová, L., Kralova, M., Šimko, M., & Muchová, J. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.02.002 · Cited by 20
Coronary Artery Disease Risk Factors From a Genetic and Developmental Perspective
Slyper, A. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.6.633 · Cited by 19
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
Rizzo, M., Christ, E., Rini, G. B., Spinas, G. A., & Berneis, K. K. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.13.2295 · Cited by 19
Mechanisms of Disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease
Godsland, I. F., Johnston, D. G., & Chaturvedi, N. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0530 · Cited by 19
Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction
Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., & Takasu, N. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.018 · Cited by 20
The case for metabolic hypertension: Is it time to restructure the hypertension paradigm?
Pool, P. E. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90020-e · Cited by 20
Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B
Charlton-Menys, V., Liu, Y., Mackness, M., CASLAKE, M. J., Kwok, S., & Durrington, P. N. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00231-6 · Cited by 20
Macrophages take up triacylglycerol‐rich emulsions at a faster rate upon co‐incubation with native and modified LDL: An investigation on the role of natural chylomicrons in atherosclerosis
Carvalho, M. D. T., Harada, L. M., Gidlund, M., Ketelhuth, D. F. J., Boschcov, P., & Quintão, E. C. R. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10020 · Cited by 20
“Other atherogenic components include the lipid triad consisting of small LDL particles, low serum concentration of high density lipoprotein (HDL) cholesterol [Austin et al., 1990], and high triacylglycerol (TAG) levels.”
Background
High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease
Tornvall, P., Karpe, F., Proudler, A. J., Båvenholm, P., Landou, C., Olivecrona, T., & Hamsten, A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90118-3 · Cited by 20
Lipid Levels in the Post-Acute Coronary Syndrome Setting
Miller, M. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.039 · Cited by 21
Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model
Gómez‐Hernández, A., Heras, N. D. L., López‐Pastor, A. R., García-Gómez, G., Infante‐Menéndez, J., González‐López, P., González‐Illanes, T., Lahera, V., Benito, M., & Escribano, Ó. (2021) · Cells · doi:10.3390/cells10082035 · Cited by 19
“Therefore, small, dense LDL may be more atherogenic than an equal number of larger cholesteryl ester-enriched LDL, since small dense LDL may be more liable to oxidation or may more readily penetrate and stick to the ECM of the artery wall [30,31].”
Background
Distribution and correlates of lipoproteins and their subclasses in black and white young adults. The Bogalusa Heart Study
Srinivasan, S. R., Segrest, J. P., Elkasabany, A., & Berenson, G. S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00514-7 · Cited by 19
“In general, the smaller, denser LDL subclass was strongly associated with CAD risk [9,14–19], while the larger, more buoyant HDL subclass showed a strong negative relationship [20–22].”
Background
Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients
Badiou, S., Thiébaut, R., Aurillac-Lavignolle, V., Dabis, F., Laporte, F., Cristol, J., & Mercié, P. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.05.007 · Cited by 19
Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: Population-based cohort study
Onat, A., Can, G., Çiçek, G., Ayhan, E., & Doğan, Y. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.027 · Cited by 19
The Cardioprotective Effect of Wine on Human Blood Chemistry
van Velden, D. P., Mansvelt, E. P. G., Fourie, E., ROSSOUW, M., & Marais, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02937.x · Cited by 19
Lipid abnormalities in Greek patients with coronary artery disease
Elisaf, M., Siamopoulos, K. C., Tselegarides, T. J., Bairaktari, E. T., Goudevenos, J. A., Tselepis, A. D., Tsolas, O., & Sideris, D. A. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02916-6 · Cited by 19
Risk Factors for Coronary Disease: the Time for a Paradigm Shift?
Dominiczak, M. H. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.147 · Cited by 19
Postprandial changes in LDL phenotypes in patients with myocardial infarction
Koba, S., Tsunoda, F., Hirano, T., Iso, Y., Suzuki, H., Geshi, E., & Katagiri, T. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01469.x · Cited by 19
Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women
Kasim-Karakas, S. E., Lane, E., Almario, R. U., Mueller, W. M., & Walzem, R. L. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90061-5 · Cited by 19
Cannabis effects on lipoproteins
Lazarte, J., & Hegele, R. A. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000575 · Cited by 18
Metabolic disorders and inflammation are associated with familial combined hyperlipemia
Díaz-Ruiz, M., Martínez-Triguero, M. L., López‐Ruiz, A., la Cruz, F. F.-D., Bañuls, C., & Hernández‐Mijares, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.009 · Cited by 19
Utility of apolipoprotein measurements in predicting incident type 2 diabetes: A Chinese cohort study
Chou, Y., You, S., Bai, C., Liao, Y.-C., Wei, C., & Sun, C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.03.001 · Cited by 19
Pathophysiology of Atherosclerosis
Prasad, K. (2000) · Springer eBooks · doi:10.1007/978-1-4612-1190-7_6 · Cited by 18
The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis
O’Brien, R. C., & Timmins, K. L. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90162-7 · Cited by 18
Evidence of QTLs on chromosomes 13q and 14q for triglycerides before and after 20 weeks of exercise training: The HERITAGE Family Study
Feitosa, M. F., Rice, T., Rankinen, T., Province, M. A., Chagnon, Y. C., Gagnon, J., Leon, A. S., Skinner, J. S., Wilmore, J. H., Després, J., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.052 · Cited by 18
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial
Galletti, F., Fazio, V., Gentile, M., Schillaci, G., Pucci, G., Battista, F., Mercurio, V., Bosso, G., Bonaduce, D., Brambilla, N., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1002-y · Cited by 18
Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia
Rosenson, R. S., Tangney, C., Levine, D. M., Parker, T. S., & Gordon, B. R. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.027 · Cited by 19
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events
Stojaković, T., Campo, A. D., Scharnagl, H., Sourij, H., Schmoelzer, I., Wascher, T. C., & März, W. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02249.x · Cited by 18
Metabolic Syndrome and Cardiovascular Disease
Soo, B., & Kim, H. J. (2003) · Korean Circulation Journal · doi:10.4070/kcj.2003.33.8.645 · Cited by 18
The fatty acid distribution in low density lipoprotein in diabetes
Prescott, J., Owens, D., Collins, P. B., Johnson, A., & TOMKIN, G. H. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00082-7 · Cited by 18
Low‐density lipoprotein subclasses in children under 10 years of age
Steinbeck, K., Bermingham, M., Mahajan, D., & Baur, L. A. (2001) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2001.00753.x · Cited by 18
Insulin resistance is not a major determinant of low-density lipoprotein particle size
Slyper, A. H., Ивановна, З. С., Schectman, G., Hoffmann, R. G., Mueller, R. A., & Walker, J. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90230-4 · Cited by 18
The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene
Naggert, J. Κ., Recinos, A., Lamerdin, J. E., Krauss, R. M., & Nishina, P. M. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02461.x · Cited by 18
Self-citation
Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study
Miyoshi, T., Nakamura, K., Doi, M., & Ito, H. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0119-2 · Cited by 17
A rapid 3% polyacrylamide slab gel electrophoresis method for high through put screening of LDL phenotype
Singh, Y. R., Ramakrishnan, L., Gupta, R., & Vemparala, K. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-47 · Cited by 17
“Serum LDL has been the subject of numerous epidemiological studies because of their unequivocal association with coronary artery disease [4].”
Metabolic Syndrome or Insulin Resistance: Evolution, Controversies and Association With Cardiovascular Disease Risk
Chopra, A. K. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620935030 · Cited by 17
Banting memorial lecture 2022: ‘Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime’
Byrne, C. D. (2022) · Diabetic Medicine · doi:10.1111/dme.14912 · Cited by 17
The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis
Berneis, K. K., Rizzo, M., Spinas, G. A., Lorenzo, G. D., Fede, G. D., Pepe, I., Pernice, V., & Rini, G. B. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.05.002 · Cited by 17
Apolipoprotein B 5’-Ins/Del and 3’-VNTR Polymorphisms in Chinese, Malay and Indian Singaporeans
Choong, M. L., Koay, E. S. C., Khaw, M.-C., & Aw, T. C. (1999) · Human Heredity · doi:10.1159/000022837 · Cited by 17
High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship
Kostapanos, M. S. (2014) · World Journal of Experimental Medicine · doi:10.5493/wjem.v4.i1.1 · Cited by 17
Diabetes to cardiovascular disease: Is depression the potential missing link?
Singh, P., Khullar, S., Singh, M., Kaur, G., & Mastana, S. S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.01.033 · Cited by 18
“C, which is significantly associated with CHD risk independent of elevated LDLs [87].”
Background
High-density lipoprotein profile in newly-diagnosed lower extremity artery disease in Slovak population without diabetes mellitus.
Kasko, M., Gašpar, Ľ., Dukát, A., Gavorník, P., & Oravec, S. (2014) · PubMed · Cited by 17
Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia
Gentile, M., Calcaterra, I. L., Strazzullo, A., Pagano, C., Pacioni, D., Speranza, E., Rubba, P., & Marotta, G. (2015) · Clinical Lipidology · doi:10.2217/clp.15.37 · Cited by 17
Molecular Basis of Obesity and the Risk for Cardiovascular Disease
Soufi, M., Sattler, A., Herzum, M., Maisch, B., & Schaefer, J. R. (2006) · Herz · doi:10.1007/s00059-006-2801-2 · Cited by 16
“This increases the ability of these LDLs to penetrate the vascular endothelium due to a greater affinity for glycans in the intima [51, 57].”
Background
Distribution and cardiovascular risk correlates of serum triglycerides in young adults from a biracial community
Frontini, M., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00538-4 · Cited by 17
Low-Density Lipoprotein Size in Primary Hypothyroidism
Roscini, A. R., Lupattelli, G., Siepi, D., Pagliaricci, S., Pirro, M., & Mannarino, E. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012806 · Cited by 17
Divergent Effects of the Catalytic and Bridging Functions of Hepatic Lipase on Atherosclerosis
Dichek, H. L., Qian, K. X., & Agrawal, N. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000135981.61827.9d · Cited by 17
Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men
Lemieux, I., Pascot, A., Tchernof, A., Bergeron, J., Prud’homme, D., Bouchard, C., & Després, J. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90275-5 · Cited by 17
[1] Apolipoproteins: Pathophysiology and clinical implications
Patsch, W., & Gotto, A. M. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63003-1 · Cited by 19
Diet and low-density lipoprotein particle size
Desroches, S., & Lamarche, B. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0086-6 · Cited by 17
Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
Ginsberg, H. N., Ngai, C. I., Wang, X. J., & Ramakrishnan, R. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.842 · Cited by 17
Triglycerides and atherosclerosis: to feast or fast
Cabezas, M. C. (2000) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(99)00127-8 · Cited by 17
Exercise and postprandial lipid metabolism
Hardman, A. E., & Herd, S. L. (1998) · Proceedings of The Nutrition Society · doi:10.1079/pns19980011 · Cited by 17
Diabetes mellitus — A priority health care issue for women
Tinker, L. F. (1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92189-x · Cited by 17
Hypothesis driven single nucleotide polymorphism search (HyDn-SNP-S)
Swett, R., Elias, A., Miller, J., Dyson, G. E., & Cisneros, G. A. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.06.001 · Cited by 16
Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus
Wanner, C., & Krane, V. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000326849 · Cited by 16
Elevated Proportion of Small, Dense Low-Density Lipoprotein Particles and Lower Adiponectin Blood Levels Predict Early Structural Valve Degeneration of Bioprostheses
Shetty, R. C., Girerd, N., Côté, N., Arsenault, B. J., Després, J., Pîbarot, P., & Mathieu, P. (2012) · Cardiology · doi:10.1159/000336170 · Cited by 16
Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients
Boumaiza, I., Omezzine, A., Rejeb, J., Rebhi, L., Kalboussi, N., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., Boughazala, E., & Bouslama, A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0006 · Cited by 16
Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus
Magge, S. N. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0274-9 · Cited by 16
“In adults, small LDL [62], large VLDL, and small HDL [63] are associated with increased CVD risk.”
Background
Lipid disorders in type 2 diabetes
Laakso, M. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73517-x · Cited by 18
“An increased number of LDL particles might contribute to atherogenesis and cardiovascular disease risk 9 .”
Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle‐aged and elderly Chinese: A cross‐sectional and prospective cohort study
Du, R., Wu, X., Peng, K., Lin, L., Li, M., Xu, Y. H., Xu, M., Chen, Y., Li, D., Lu, J., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12904 · Cited by 16
“In 1990, Austin et al.(7) reported that Phenotype B of LDL subclasses consisted of a major peak of small, dense LDL particles that was associated with increased plasma concentrations of apolipoprotein (apo) B.”
Background
Distribution and Cardiovascular Risk Correlates of Serum Triglycerides in Young Japanese Adults.
Nakanishi, N., OKAMOTA, M., Makino, K., SUZUKI, K. S., & Tatara, K. (2002) · Industrial Health · doi:10.2486/indhealth.40.28 · Cited by 15
Dietary carbohydrate and cholesterol influence the number of particles and distributions of lipoprotein subfractions in guinea pigs
Torres‐Gonzalez, M., Volek, J. S., Sharman, M. J., Contois, J. H., & Fernández, M. L. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.01.004 · Cited by 16
“In the last years, investigations about the incidence of CVDs have been related with LDL particle size [41,42].”
Background
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension
Saiki, A., Ohira, M., Endo, K., Koide, N., Oyama, T., Murano, T., Miyashita, Y., & Shirai, K. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.004 · Cited by 16
Phospholipase A2 Modification of Lipoproteins: Potential Effects on Atherogenesis
Sartipy, P., Camejo, G., Svensson, L., & Hurt‐Camejo, E. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_1 · Cited by 16
Lipoprotein metabolism in non-insulin-dependent diabetes mellitus
BARAKAT, H., Vadlamudi, S., MacLean, P. S., MACDONALD, K., & Pories, W. J. (1996) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(96)00117-9 · Cited by 16
Familial Combined Hyperlipidemia and Insulin Resistance
Eckel, R. H. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.469 · Cited by 16
What have we learnt about high-density lipoprotein cholesterol measurements during 32years? Experiences in Finland 1980–2012
Leiviskä, J., Sundvall, J., Alfthan, G., Tähtelä, R., Salomaa, V. V., Jauhiainen, M., & Vartiainen, E. A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.10.027 · Cited by 15
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene
López‐Ruiz, A., Jarabo-Bueno, M. M., Martínez-Triguero, M. L., Morales‐Suárez‐Varela, M., Solá, E., Bañuls, C., Casado, M., & Hernández‐Mijares, A. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-12 · Cited by 15
“This lipid triad frequently occurs in patients with premature coronary disease [2].”
Background
The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study
Aneni, E. C., Bittencourt, M. S., Teng, C., Cainzos‐Achirica, M., Osondu, C. U., Soliman, A., Al-Mallah, M. H., Buddoff, M. J., Parise, E. R., Santos, R. D., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100097 · Cited by 15
“Atherogenic dyslipidemia, defined as elevated levels of triglycerides, and small-dense LDL with low levels of HDL-cholesterol is a central feature in the development of diabetes and is a marker of both metabolic syndrome and insulin resistance [18].”
Background
The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study
Lokpo, S. Y., Laryea, R., Osei-Yeboah, J., Owiredu, W. K. B. A., Ephraim, R. K. D., Adejumo, E. N., Ametepe, S., Appiah, M., Peter, N., Affrim, P. K., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10279 · Cited by 18
Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus
Sliem, H. A., Abd-Allha, E., Hassan, B., Abduo, M., & Omar, S. A. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.126585 · Cited by 15
“Low density lipoprotein (LDL) consists of a heterogeneous spectrum of particles with highly variable atherogenic potential.[15] Small dense LDL (sdLDL) particles are believed to be particularly atherogenic due to increased susceptibility to oxidation,[16,17] high endothelia permeability,[18] decreased LDL receptor aff…”
Background
Hypertriglyceridemia and insulin resistance
HÖlzl, Paulweber, Sandhofer, & Patsch (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00261.x · Cited by 15
Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome
Kim, Y., Seo, H. S., Lee, E. M., Na, J. O., Choi, C. U., Lim, H. E., Kim, E. J., Rha, S., Park, C. G., & Oh, D. J. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.86 · Cited by 15
Clinical applications of advanced lipoprotein testing in diabetes mellitus
Moin, D. S., & Rohatgi, A. K. (2011) · Clinical Lipidology · doi:10.2217/clp.11.37 · Cited by 15
Atherogenic Dyslipidemia Remission 1 Year After Bariatric Surgery
Climent, E., Benaiges, D., Pedro‐Botet, J., Roux, J. A. F., Ramón, J. M., Villatoro, M., Fontané, L., Chillarón, J. J., & Goday, A. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2504-6 · Cited by 15
ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients
Grzegorzewska, A. E., Niepolski, L., Świderska, M. K., Mostowska, A., Stolarek, I., Warchol, W. J., Figlerowicz, M., & Jagodziński, P. P. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0708-4 · Cited by 15
Predominance of Small Dense Low-Density Lipoproteins and Abnormal Glucose Regulation in Patients With Acute Coronary Syndrome
Ban, Y., Koba, S., Tsunoda, F., Yokota, Y., Ezumi, H., Kondo, T., Suzuki, H., & Katagiri, T. (2006) · Circulation Journal · doi:10.1253/circj.70.393 · Cited by 15
Effect of Atorvastatin on the Concentration, Relative Distribution, and Chemical Composition of Lipoprotein Subfractions in Patients With Dyslipidemias of Type IIA and IIB
Tsimihodimos, V., Karabina, S.-A. P., Tambaki, A. P., Bairaktari, E. T., Achimastos, A. D., Tselepis, A. D., & Elisaf, M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200308000-00021 · Cited by 15
“In this context, some investigators have proposed a critical concentration of 120 mg/dL to exist for the classification “high” or “low” triglyceride values.(20) Based on these assumptions, we can speculate that the atorvastatin-induced reduction in triglyceride concentration in type IIB patients (resulted from reduced…”
Background
Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea
Tisko, R., Sopkova, Z., Habalová, V., Dorková, Z., Slabá, E., Javorský, M., Tkáč, I., Riha, R. L., & Tkáčová, R. (2013) · European Respiratory Journal · doi:10.1183/09031936.00098513 · Cited by 15
LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM
Betteridge, D. J. (1997) · Diabetologia · doi:10.1007/s001250051434 · Cited by 15
Effect of Desirable Fasting Triglycerides on the Postprandial Response to Dietary Fat
Miller, M. J., Zhan, M., & Georgopoulos, A. (2003) · Journal of Investigative Medicine · doi:10.2310/6650.2003.33544 · Cited by 15
When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines
Pedro‐Botet, J., Sentı́, M., Rubiés-Prat, J., Pelegrí, A., & Romero, R. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027258 · Cited by 15
Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia
Vázquez‐Carrera, M., Zambón, D., Hernández, Y., Adzet, T., Merlos, M., Ros, E., & Laguna, J. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00672.x · Cited by 15
Aortic stiffness in diabetes mellitus – association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model
Uğurlucan, M., Erer, D., Kalko, Y., Güngör, F., Haholu, A., Başaran, M., Banach, M., Rysz, J., Mikhailidis, D. P., Tirelı, E., et al. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902735833 · Cited by 14
Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: Reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study
Leiviskä, J., Sundvall, J., Alfthan, G., Jauhiainen, M., & Salomaa, V. V. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.015 · Cited by 14
“The combination of elevated VLDL, small dense LDL, and decreased HDL, also called the atherogenic lipid triad, is a common feature in the metabolic syndrome [10].”
A new approach to the quantitative measurement of dense LDL subfractions
Berg, G. A., Muzzio, M. L., Wikinski, R. L. W., & Schreier, L. E. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80013-9 · Cited by 14
LDL Species Heterogeneity in the Atherogenic Dyslipidemia of Polycystic Ovary Syndrome
Doi, S. A. R., Abbas, J. M. K., Parkinson, L., Chakraborty, J., & Akanji, A. O. (2008) · American Journal of Clinical Pathology · doi:10.1309/e7egttvcrfvba7ec · Cited by 15

Authors: Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M.
Affiliations: University of California, Berkeley (US)
ORCID: King, M C
Krauss, R M
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 82
Issue: 2
Pages: 495-506
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.82.2.495
OpenAlex: W2089286420
Cited by: 1,411
References: 63
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 39 · 2022: 20 · 2021: 26 · 2020: 25 · 2019: 27 · 2018: 17 · 2017: 21 · 2016: 27 · 2015: 42 · 2014: 38 · 2013: 46 · 2012: 39
FWCI: 47.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy (DE-AC03-?, AC03-76SF00098, DEAC03-76SF00098)
National Institutes of Health (7r29hl038760-03, 5p01hl018574-26, DE-AC03- 76SF00098)
National Heart, Lung, and Blood Institute (HL38760, HL-18574)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: atherogenic lipoprotein phenotype, LDL subclasses, low-density lipoprotein, coronary heart disease risk, genetic markers, single-gene inheritance, apolipoprotein B, apolipoprotein A-I, HDL cholesterol, HDL2, triglycerides, VLDL, intermediate density lipoprotein
MeSH terms: Adolescent, Adult, Aged, Arteriosclerosis, Child, Child, Preschool, Chromosome Mapping, Coronary Disease, Female, Genetic Markers, Humans, Lipids, Lipoproteins, Cholesterol, HDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks